Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 9710050.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This report describes the effectiveness of gabapentin, a recently approved anticonvulsant, in seven patients with MS experiencing trigeminal neuralgia refractory to treatment with conventional medical therapy. Gabapentin relieved pain completely in six and significantly in the seventh patient. Gabapentin may be a valuable addition to pharmacologic therapy in trigeminal neuralgia, particularly in patients with MS and in refractory cases.
Medical subject headings
- Acetates
- Amines
- Analgesics
- Cyclohexanecarboxylic Acids
- Multiple Sclerosis
- Trigeminal Neuralgia
- gamma-Aminobutyric Acid